Relmada Therapeutics (RLMD) Payables (2012 - 2026)
Relmada Therapeutics' Payables came in at $2.41 million for Q2 2026, up 76.9% from $1.36 million a year earlier but down 58.0% from the prior quarter.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Payables (2012 - 2026) Analysis & Trends
At the end of FY2025, Relmada Therapeutics' Payables was $1.57 million, down 62.0% from FY2024.
- Payables carries a five-year compound annual growth rate of -28.4% (FY2020 to FY2025).
- Going back by year, Payables was $4.13 million in FY2024 (+17.8%), $3.51 million in FY2023 (-33.4%), $5.26 million in FY2022 (-53.0%) and $11.19 million in FY2021 (+34.1%).
- The five-year range for quarterly Payables is $1.27 million (Q1 2025) to $12.71 million (Q3 2021).
- Year-over-year, Payables increased in three of the last eight quarters, with growth averaging 18.4%.
- The fastest year-over-year change in Payables over five years came in Q1 2026 (growth of 353.1%), and the weakest in Q1 2025 (a decline of 75.6%).
- Business Quant data shows RLMD's Payables at $5.73 million (Q1 2026), $1.57 million (Q4 2025) and $1.45 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 20.92 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 7.03 Bn |
| 10 | Relmada Therapeutics | 361.29 Mn | -197.30 Mn | - | 2.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.41 Mn |
| Mar 31, 2026 | 5.73 Mn |
| Dec 31, 2025 | 1.57 Mn |
| Sep 30, 2025 | 1.45 Mn |
| Jun 30, 2025 | 1.36 Mn |
| Mar 31, 2025 | 1.27 Mn |
| Dec 31, 2024 | 4.13 Mn |
| Sep 30, 2024 | 2.35 Mn |
| Jun 30, 2024 | 4.17 Mn |
| Mar 31, 2024 | 5.19 Mn |
| Dec 31, 2023 | 3.51 Mn |
| Sep 30, 2023 | 5.57 Mn |
| Jun 30, 2023 | 4.85 Mn |
| Mar 31, 2023 | 4.42 Mn |
| Dec 31, 2022 | 5.26 Mn |
| Sep 30, 2022 | 10.43 Mn |
| Jun 30, 2022 | 7.54 Mn |
| Mar 31, 2022 | 10.67 Mn |
| Dec 31, 2021 | 11.19 Mn |
| Sep 30, 2021 | 12.71 Mn |
API Access
Relmada Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();